Allogene Therapeutics (ALLO) Asset Utilization Ratio (2021 - 2025)
Historic Asset Utilization Ratio for Allogene Therapeutics (ALLO) over the last 4 years, with Q4 2024 value amounting to 0.0.
- Allogene Therapeutics' Asset Utilization Ratio fell 7239.67% to 0.0 in Q4 2024 from the same period last year, while for Dec 2024 it was 0.0, marking a year-over-year decrease of 7239.67%. This contributed to the annual value of 0.0 for FY2024, which is 7153.89% down from last year.
- Per Allogene Therapeutics' latest filing, its Asset Utilization Ratio stood at 0.0 for Q4 2024, which was down 7239.67% from 0.0 recorded in Q3 2024.
- Allogene Therapeutics' 5-year Asset Utilization Ratio high stood at 0.11 for Q4 2021, and its period low was 0.0 during Q4 2024.
- In the last 4 years, Allogene Therapeutics' Asset Utilization Ratio had a median value of 0.0 in 2023 and averaged 0.03.
- As far as peak fluctuations go, Allogene Therapeutics' Asset Utilization Ratio skyrocketed by 13545.26% in 2022, and later tumbled by 9983.58% in 2023.
- Quarter analysis of 4 years shows Allogene Therapeutics' Asset Utilization Ratio stood at 0.11 in 2021, then tumbled by 99.83% to 0.0 in 2022, then dropped by 22.95% to 0.0 in 2023, then tumbled by 72.4% to 0.0 in 2024.
- Its Asset Utilization Ratio stands at 0.0 for Q4 2024, versus 0.0 for Q3 2024 and 0.0 for Q2 2024.